BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8537722)

  • 21. [Cimetidine in the treatment of secondary hyperparathyroidism in uremia treated with hemodialysis].
    Antonucci F; Gropuzzo M; Messa PG; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Mioni G
    Minerva Med; 1985 Mar; 76(9-10):403-6. PubMed ID: 3885074
    [No Abstract]   [Full Text] [Related]  

  • 22. The DOPPS Practice Monitor for US Dialysis Care: PTH Levels and Management of Mineral and Bone Disorder in US Hemodialysis Patients.
    Tentori F; Zepel L; Fuller DS; Wang M; Bieber BA; Robinson BM; Pisoni RL
    Am J Kidney Dis; 2015 Sep; 66(3):536-9. PubMed ID: 26300197
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dialysis bone disease associated with secondary hyperparathyroidism].
    Nakazawa R
    Nihon Rinsho; 1992 Jan; 50 Suppl():783-8. PubMed ID: 1578767
    [No Abstract]   [Full Text] [Related]  

  • 24. [Metastatic calcinosis or calciphylaxis--a case with a severe vascular calcification during intermittent hemodialysis].
    Pogglitsch H; Feldner H; Stöckl G; Holzer H
    Wien Med Wochenschr; 1970 Jul; 120(30):532-4. PubMed ID: 5523384
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.
    Fukagawa M; Yokoyama K; Koiwa F; Taniguchi M; Shoji T; Kazama JJ; Komaba H; Ando R; Kakuta T; Fujii H; Nakayama M; Shibagaki Y; Fukumoto S; Fujii N; Hattori M; Ashida A; Iseki K; Shigematsu T; Tsukamoto Y; Tsubakihara Y; Tomo T; Hirakata H; Akizawa T; ;
    Ther Apher Dial; 2013 Jun; 17(3):247-88. PubMed ID: 23735142
    [No Abstract]   [Full Text] [Related]  

  • 26. [Total parathyroidectomy without autotransplantation in the management of "refractory" renal hyperparathyroidism].
    Diaconescu MR; Glod M; Costea I; Grigorovici M; Diaconescu S
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):105-10. PubMed ID: 21688566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.
    O'Riordan JL; Page J; Kerr DN; Walls J; Moorhead J; Crockett RE; Franz H; Ritz E
    Q J Med; 1970 Jul; 39(155):359-76. PubMed ID: 5478506
    [No Abstract]   [Full Text] [Related]  

  • 28. Bone disease in uremia.
    Coburn JW
    Henry Ford Hosp Med J; 1983; 31(4):217-20. PubMed ID: 6674267
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of bone mineral content in patients with chronic renal failure.
    Gava A; Zorzetto M; Coghetto F; Teodori T; Marazzato G
    Rays; 1986; 11(3):67-70. PubMed ID: 3602467
    [No Abstract]   [Full Text] [Related]  

  • 30. Mineral and bone disorders outcomes study for Japanese chronic kidney disease stage 5D patients: rationale and study design.
    Fukuhara S; Akizawa T; Fukagawa M; Onishi Y; Yamaguchi T; Hasegawa T; Kurokawa K
    Ther Apher Dial; 2011 Apr; 15(2):169-75. PubMed ID: 21426510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How to apply and adapt international guidelines on bone metabolism and disease to the management of Japanese dialysis patients.
    Fukagawa M; Akizawa T
    Ther Apher Dial; 2005 Feb; 9(1):1-2. PubMed ID: 15828896
    [No Abstract]   [Full Text] [Related]  

  • 32. Commentary on 'the DOPPS practice monitor for US dialysis care: potential impact of recent guidelines and regulatory changes on management of mineral and bone disorder among US hemodialysis patients': the calm before the 2016 storm?
    Weiner DE; Winkelmayer WC
    Am J Kidney Dis; 2014 May; 63(5):854-8. PubMed ID: 24725918
    [No Abstract]   [Full Text] [Related]  

  • 33. [Biochemical markers of bone formation in hemodialysis and after allotransplantation of cadaveric kidney].
    Ermakova IP; Pronchenko IA; Buzulina VP; Nikonova TIu; Borisova AV
    Ter Arkh; 2006; 78(10):73-6. PubMed ID: 17180944
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Aluminum poisoning].
    Cervar M; Stavljenic A; Vukicević S
    Lijec Vjesn; 1989; 111(4-5):164-9. PubMed ID: 2671563
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperparathyroidism in urology].
    Koide T
    Clin Calcium; 2005 Dec; 15(12):73-8. PubMed ID: 16322677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Outlines of K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease in Chronic Kidney Disease].
    Orita H; Akizawa T
    Clin Calcium; 2004 May; 14(5):693-7. PubMed ID: 15577029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of metabolic bone disease in haemodialysis patients.
    Hussain R; Ahmed A; Soomro AS; Chishty SH; Naqvi SA
    J Pak Med Assoc; 1996 Apr; 46(4):83-6. PubMed ID: 8991360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium and phosphorus metabolism in maintenance hemodialysis.
    Ritz E; Mehls O; Krempien B
    Adv Nephrol Necker Hosp; 1980; 9():71-108. PubMed ID: 6773320
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolic bone disease in patients on maintenance hemodialysis.
    Ritz E; Malluche H; Bommer J; Mehls O; Krempien B
    Nephron; 1974; 12(5):393-404. PubMed ID: 4824048
    [No Abstract]   [Full Text] [Related]  

  • 40. Spontaneous bilateral quadriceps tendon rupture in a patient on hemodialysis.
    Anderson WE; Habermann ET
    Orthop Rev; 1988 Apr; 17(4):411-4. PubMed ID: 3405626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.